BRIXADI
NDC 58284-216, BUPRENORPHINE, injection, from Braeburn Inc..
- Product NDC
- 58284-216
- Status
- Listed
- Labeler
- Braeburn Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210136
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/58284-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUPRENORPHINE16 mg/.32mL
Pharmacologic classes
Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 58284-216-01 | 58284021601 | 1 SYRINGE, GLASS in 1 CARTON (58284-216-01) / .32 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5d8a8fd0-8619-422a-a664-d1d2e8970f48Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=58284-216
Use it
Look up 58284-216 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/58284-216 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 58284-216. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.